'Watch and Switch' Strategy Extends PFS in HR-Positive Breast Cancer

Progression-free survival doubled with treatment change based on monitoring for resistance marker

Related Keywords

Saclay ,France General ,France ,United States ,Paris ,Fort Pierce ,Florida ,Minnesota ,Mayo Clinic In Rochester ,San Antonio ,Texas ,Ed Susman ,Institut Curie Universit ,Circulating Tumor ,San Antonio Breast Cancer ,Mayo Clinic ,Antonio Breast Cancer ,